Medical College of Wisconsin
CTSIResearch InformaticsREDCap

Subsequent Malignant Neoplasms in Childhood Cancer Survivors: Identifying Risks and Screening Recommendations. Hematol Oncol Clin North Am 2026 Jun;40(3):403-415

Date

06/11/2026

Pubmed ID

42270201

DOI

10.1016/j.hoc.2026.02.002

Scopus ID

2-s2.0-105041600055 (requires institutional sign-in at Scopus site)

Abstract

A subsequent malignant neoplasm (SMN) is defined as a distinctly new histologic malignant neoplasm that occurs after completion of treatment of a primary malignancy or hematopoietic stem cell transplant. The risk for SMNs in survivors is estimated to be between 2% and 20%. Many risk factors associated with the development of SMNs including radiation, chemotherapy, underlying genetic diagnoses, and lifestyle factors, which all must be understood to provide appropriate SMN screening recommendations for survivors. Many different screening guidelines exist-choosing the appropriate set for each patient requires an understanding of all factors that impact individualized SMN risk.

Author List

Becktell K, Cotchett K, Volmy R, Phelan R

Authors

Kerri Becktell MD Associate Professor in the Pediatrics department at Medical College of Wisconsin
Rachel A. Phelan MD, MPH Professor in the Pediatrics department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Cancer Survivors
Child
Early Detection of Cancer
Humans
Neoplasms
Neoplasms, Second Primary
Risk Factors